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Background Childhood eczema is variable in onset and persistence.
Objectives To identify eczema phenotypes during childhood, and their associations
with early-life environmental and genetic factors.
Methods In this study of 5297 children from a multiethnic population-based
prospective cohort study, phenotypes based on parent-reported physician-diag-
nosed eczema from age 6 months to 10 years were identified using latent class
growth analysis. Information on environmental factors was obtained using postal
questionnaires. Four filaggrin mutations were genotyped and a risk score was cal-
culated based on 30 genetic variants. Weighted adjusted multinomial models
were used for association analyses.
Results We identified the following five eczema phenotypes: never (76%), early tran-
sient (8%), mid-transient (6%) and late transient (8%) and persistent eczema (2%).
Early transient and persistent eczema were most common in first-born children, those
with a parental history of eczema, allergy or asthma and those with persistent wheez-
ing [range of odds ratio (OR): 1.37, 95% confidence interval (CI) 1.07–1.74 and OR
3.38, 95%CI 1.95–5.85]. Early transient eczema was most common in male children
only (OR 149, 95% CI 118–189). Children with late transient or persistent eczema
were more often of Asian ethnicity (OR 204, 95% CI 114–365 and OR 308, 95%
CI 134–710, respectively). Children with early, late transient and persistent eczema
more often had a filaggrin mutation or additional risk alleles (range OR: 1.07, 95%CI
1.02–1.12 and OR 2.21, 95%CI 1.39–3.50). Eczema phenotypes were not associated
with maternal education, breastfeeding, day care attendance and pet exposure.
Conclusions Five eczema phenotypes were identified in a multiethnic paediatric
population with limited differences in risk profiles, except for sex and ethnicity.
What’s already known about this topic?
• Two previous studies in longitudinal birth cohorts identified four and six different
eczema phenotypes, predominantly in children of European ethnicity.
What does this study add?
• Five eczema phenotypes were identified in a multiethnic paediatric population
using latent class growth analysis.
• Children with early transient and persistent eczema were most often first-born chil-
dren and had persistent wheezing, filaggrin mutation or additional risk alleles.
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• Previously known eczema risk factors had limited differentiating capabilities for
eczema phenotypes, except for the association of early transient eczema with male
children, and late transient and persistent eczema with Asian ethnicity.
Childhood eczema is a major common chronic health problem
with a prevalence of up to 25%.1 The age of onset and the
persistence of eczema during childhood vary. There is a need
to define more detailed eczema phenotypes and to understand
their specific underlying risk factors in order to make better
predictions about the natural course of eczema and to prevent
the onset and worsening of eczema. Defining eczema as a
dichotomous trait is an oversimplification. Eczema phenotypes
that take into account the age of onset and persistence over
time may enable better identification of specific environmental
exposures and genetic mechanisms that might play a role in
the development of eczema.2–4 Previous studies suggest that
higher maternal education, non-European ethnicity, having
older siblings, shorter duration or nonexclusivity of breast-
feeding, day care attendance and no pet exposure are associ-
ated with an increased risk of childhood eczema.5–11 In
addition, loss-of-function mutations in the gene encoding
filaggrin (FLG), an indispensable protein for epidermal differ-
entiation and maintenance of an optimal skin barrier, are well
known to be associated with eczema.12 Furthermore, genome-
wide association (GWA) studies identified 31 variants that
were associated with childhood eczema.13–15 It is unclear
whether these early-life exposures and genetic variants are
related to the various eczema phenotypes. Two previous longi-
tudinal birth cohorts identified different eczema phenotypes
with sex, parental history of eczema, asthma or allergies,
breastfeeding, pet exposure, FLG mutations, genetic risk score,
asthma and other allergenic comorbidities as determi-
nants.15,16 However, those cohorts consisted predominantly of
children of European ethnicity, did not take repeated measure-
ments of eczema into account in the cluster analysis, or only
explored the risk of early-life exposures and genetic variants
in unadjusted analyses.
Therefore, in order to predict and prevent the natural
course of eczema, we aimed to identify eczema phenotypes in
a multiethnic population-based prospective cohort study
among 5297 children. We further examined the associations
of socioeconomic and lifestyle exposures in early-life and
genetic risk factors with the identified eczema phenotypes.
Patients and methods
Design
This study was embedded in the Generation R Study, a
population-based prospective cohort study from early fetal
life onwards.17 Written informed consent was obtained
from parents or legal guardians. Of 7893 live-born children
participating after birth, those without data on physician-
diagnosed eczema available for at least three time points
were excluded, leaving a total of 5297 children for the
current analyses.
Eczema definition
Information on eczema was obtained from parental question-
naires at age 6 months, and at ages 1, 2, 3, 4 and 10 years
(response rates 72–76%). Physician-diagnosed eczema was
defined as a positive response to the question ‘Was your child
diagnosed with eczema in the last 6 months/last year by a
physician?’ (no/yes).7 This question was adapted from the
core questionnaire of the International Study of Asthma and
Allergies in Childhood (ISAAC).18
Early-life environmental exposures
Information on parity (nulliparous/multiparous), maternal
education (primary or secondary school/higher than sec-
ondary school), and parental history of eczema, allergy or
asthma (no/ yes) was available from parental questionnaires
obtained at enrolment. Information on the sex of the child
was obtained from midwives and hospital records. Ethnic
origin (European/non-European) of the child was based on
the parents’ country of birth according to Statistics Nether-
lands.17 Postnatal questionnaires provided information on
breastfeeding (never/ever) at 2, 6 or 12 months after birth,
pet exposure at ages 2 months and 6 months (no/yes, expo-
sure to cat, dog, rodent or bird at home) and day care
attendance at age 12 months (yes/no). Questionnaires
adapted from the ISAAC study were used to determine
wheezing at ages 1–6 years (no/yes).18 Wheezing patterns
were classified based on time of onset and persistence as
‘never’, ‘early’ (wheezing at age ≤ 3 years only), ‘late’
(wheezing at ages > 3–6 years only), or ‘persistent wheez-
ing’ (wheezing at age ≤ 3 years and at age > 3–6 years) for
children with data on wheezing available for at least two
time points.19
Genetic risk factors
The most prevalent FLG mutations in European populations
(2282del4, R2447X, R501X and S3247X) were genotyped by
modified Taqman allelic discrimination assays using previously
described primers.20,21 Children without any mutant alleles
were classified as wild-type. As we observed only two cases of
homozygous FLG mutations, we created a combined FLG
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genotype (no mutation/one mutation or more).22 A recent
and large GWA study identified and replicated 30 single-
nucleotide polymorphisms (SNPs) that were associated with
childhood eczema.13 Information on these SNPs was available
from the GWA screening performed on DNA isolated from
cord blood leucocytes or, in a small minority of children with
missing cord blood samples, at age 6 years using the Illumina
670K platform.17 Genotype data were imputed for all poly-
morphic SNPs into the 1000 Genomes panel. A genetic risk
score for each individual was calculated by summation of the
number of eczema-increasing risk alleles (between 0 and 2 for
each SNP) across all SNPs.13
Statistical analysis
Firstly, we compared characteristics of individuals included
in our study with those who were not included by using
independent sample t-test, Mann–Whitney U-test and Pear-
son’s v2-tests. Secondly, eczema phenotypes were identified
using latent class growth analysis based on parent-reported
physician-diagnosed eczema data. This type of analysis
assumes that a number of different latent classes exist in
the study population, which describe the variation of
observed responses over time, and clusters individuals with
similar patterns while taking into account correlations
between measurements from the same individual.23–25
Details on model selection are provided in the Supporting
Information. For comparison with previous studies on
eczema subgroups, we performed longitudinal latent class
analysis to identify eczema phenotypes.15,16 Thirdly, we
examined the associations of early environmental exposures
and genetic risk factors with the identified eczema pheno-
types using weighted mutually adjusted multinomial regres-
sion models. Multiple imputation using chained equations
was used to impute missing values of environmental expo-
sures (range 0–30% per variable). Twenty completed data-
sets were created and the results were pooled using
Rubin’s rules.26 Physician-diagnosed eczema, FLG genotype
and the calculated genetic risk score were not imputed as
they could not be appropriately predicted from the avail-
able data.27 Finally, in order to examine the associations
between different ethnicities and eczema phenotypes in
more detail, we divided ethnicity into European (European,
American or Oceanian), Mediterranean (Turkish or Moroc-
can), Asian (Asian, Indonesian, Surinamese–Hindustani or
Surinamese–mixed) and African (African, Dutch–Antillean
or Surinamese–Creole) subgroups based on similarities in
skin type and cultural background.11,28 All measures of
association are presented as odds ratios (ORs) with corre-
sponding 95% confidence intervals (CIs). Latent class analy-
ses were performed using Mplus (version 711) for
Windows (Muthen and Muthen, Los Angeles, CA, U.S.A.),
imputation and weighted multinomial regression analyses
were performed using the packages ‘mice’ (version
2460)29 and ‘nnet’ (version 7312) in R version 343,30
respectively.
Results
Parental and child characteristics
Maternal and child characteristics are presented in Table 1.
The prevalence of eczema declined from 16% (n = 662) at
age 6 months to 7% (n = 347) at age 10 years. Individuals
who were not included in the current analyses had somewhat
less favourable socioeconomic and environmental factors
(Table S1; see Supporting Information).
Eczema phenotypes
In children with data on physician-diagnosed eczema available
from at least three time points (n = 5297), latent class growth
analysis identified the model with five eczema phenotypes as
the best fit (Fig. 1, Tables S2, S3; see Supporting Informa-
tion). The five eczema phenotypes were described as never
eczema (76%), early transient eczema (8%), mid-transient





Parity (nulliparous) 3096 (59)
Maternal education (higher) 3009 (57)
History of eczema, allergy and
asthma (yes, at least one parent)
3189 (60)
Child characteristics
Sex (male) 2632 (50)
Ethnicity (non-European) 1359 (26)
Breastfeeding (ever) 4885 (92)
Day care attendance (yes) 3145 (59)






FLG genotype (≥ 1 mutations)a 247 (8)
Genetic risk score, mean  SDa 31  345
Physician-diagnosed eczemaa
6 months 662 (16)
1 years 637 (13)
2 years 719 (14)
3 years 442 (9)
4 years 378 (8)
10 years 347 (7)
Data are presented as n (%) unless stated otherwise. Values are
based on 20 imputed datasets. aData on FLG genotype, genetic
risk score and physician-diagnosed eczema were not imputed.
Data were missing for FLG genotype [n = 2186 (41%)], genetic
risk score [n = 1880 (36%)], and physician-diagnosed eczema at
6 months [n = 1569 (30%)], 1 year [n = 730 (14%)], 2 years
[n = 457 (9%)], 3 years [n = 726 (14%)], 4 years [n = 789
(15%)] and 10 years [n = 1418 (27%)].
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eczema (6%), late transient eczema (8%) and persistent
eczema (2%). Similar results were observed in children with
data on physician-diagnosed eczema available at all six time
points (n = 1975) (Table S2; see Supporting Information). To
compare our results with previous studies, we used longitudi-
nal latent class analysis and identified that the model with
three, not five, eczema phenotypes was the best fit for our
data (Table S3, Fig. S1a, b; see Supporting Information). The
three phenotypes were similar in pattern to the never, early
transient and persistent eczema phenotypes identified using
latent class growth analysis.
Early environmental exposures and eczema phenotypes
No major differences in the magnitude or the direction of
the effect estimates were observed between analyses with
imputed data and analyses with complete cases only. Here,
we present only the results based on imputed data. Nullipar-
ity and parental history of eczema, allergy or asthma were
positively associated with early transient and persistent
eczema compared with never eczema and reference groups
(OR range 137, 95% CI 107–174 and OR 201, 95% CI
120–336, respectively) (Table 2). Boys were significantly
more likely to have early transient eczema (OR 149, 95%
CI 118–189), while non-European ethnicity was associated
with late transient (OR 135, 95% CI 103–178) and persis-
tent eczema (OR 174, 95% CI 1.09–2.79). Children with
late-onset wheezing had higher risks for early transient and
persistent eczema (OR 265, 95% CI 167–420 and OR
363, 95% CI 171–771, respectively) than children classi-
fied as ‘never wheezing’ and ‘never eczema’. Children with
persistent wheezing more often had early and late transient,
and persistent eczema (OR 267, 95% CI 194–369; OR
189, 95% CI 136–265 and OR 350, 95% CI 203–604,
respectively) than children classified as ‘never wheezing’ and
‘never eczema’. No other significant associations of early
environmental exposures with eczema phenotypes were
observed.
Genetic risk factors and eczema phenotypes
Children with one or more FLG mutations had increased risks
of early and late transient eczema (OR 221, 95% CI 140–
349 and OR 209, 95% CI 130–334, respectively) compared
with children without FLG mutations and those classified as
‘never eczema’ (Table 3). For each additional risk allele in the
genetic risk score, children had increased risks of early tran-
sient and persistent eczema (OR 108, 95% CI 103–113 and
109, 95% CI 101–118, respectively). The size and the direc-
tion of the effect estimates of the associations of genetic risk
factors with eczema phenotypes remained similar when we
additionally adjusted for all early environmental exposures.
Also, the size and the direction of the effect estimates of the
associations of early environmental exposures with eczema
phenotypes remained similar, although some were attenuated
to nonsignificant when we additionally adjusted for FLG geno-
type and the genetic risk score (Table S4; see Supporting
Information).
Fig 1. Eczema phenotypes trajectories from latent class growth analysis.
© 2019 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
British Journal of Dermatology (2019)
4 Environmental and genetic risk factors of eczema phenotypes, C. Hu et al.
Ethnicity and eczema phenotypes
After dividing ethnicity into more detailed subgroups in our
early environmental exposure model, we observed that Asian
and African ethnicity were positively associated with late tran-
sient (OR 183, 95% CI 120–280 and OR 149, 95% CI
100–223, respectively) and persistent eczema (OR 226,
95% CI 111–460 and OR 201, 95% CI 106–379, respec-
tively), compared with ‘never eczema’ and European ethnicity
(Tables 3, S5; see Supporting Information). When we addi-
tionally adjusted for genetic risk factors, only the associations
of Asian ethnicity with an increased risk for late transient (OR
204, 95% CI 114–365) and persistent eczema (OR 308,
95% CI 134–710) remained (Tables 3, S6; see Supporting
Information).
Discussion
Five eczema phenotypes were identified in a multiethnic pae-
diatric population, which was followed from birth until age
10 years, based on age of onset and persistence of eczema.
Several known risk factors for eczema were associated with
distinct phenotypes, but no clear patterns emerged, which
suggests that the previously known eczema risk factors have
limited differentiating capacities for eczema phenotypes. Most
of the associations were found in relation to early transient
and persistent eczema. Early transient and persistent eczema
were most common in first-born children, those with a paren-
tal history of eczema, allergy or asthma and those with persis-
tent wheezing. Early transient eczema was most common in
male children only. Children with late transient or persistent
eczema were more often of Asian and African ethnicity.
Eczema phenotypes were not associated with maternal
education, breastfeeding, day care attendance or pet exposure.
Children with early and late transient and persistent eczema
more often had a filaggrin mutation or additional risk alleles
in the genetic risk score. Most effect estimates did not materi-
ally change when we adjusted our analyses for both environ-
mental and genetic factors. The explanation of why early
transient and persistent eczema phenotypes share several deter-
minants is not clear, but both patterns are dominant around
the age of 1 year. This may be an important age in relation to
exposure to environmental factors and the expression of
genetic predisposition in the maturation of the skin and the
immune system leading to the development of eczema.31
In our study, never, early transient and late transient and
persistent eczema showed a similar pattern as those identified
in a cohort study among 1038 children followed from birth
until age 6 years.16 Compared with a different study among
3652 and 9894 children followed from birth until age 11
years and 16 years,15 higher early eczema probabilities were
observed with steeper resolving curves, and no phenotype was
identified with an onset after age 6 years. There was a greater
degree of similarity in the patterns when we used longitudinal
latent class analysis. However, this analysis does not take
repeated measurements into account, which we considered
relevant in this study because eczema measurements were
taken at different time intervals. The remaining discrepancy in
number and pattern of phenotypes might be explained by the
differences in follow-up time (10 years compared with 6
years and 11–16 years in the other studies),15,16 number of
repeated eczema measurements (six measurements compared
with seven and 10–12), eczema definition (physician-diag-
nosed eczema vs. itchy rash on specific locations) and popula-
tion characteristics (multiethnic vs. mostly European
ethnicity).
Table 2 Associations of early environmental exposures with eczema phenotypes
Early transient
eczema, n = 439
Mid-transient
eczema, n = 306
Late transient




model, n = 5297
Parity (nulliparous) 137 (107–174) 138 (098–195) 110 (088–139) 165 (106–255)
Maternal education (higher) 104 (080–136) 111 (076–161) 104 (080–135) 070 (044–112)
Parental history of eczema,
allergy or asthma (yes)
171 (129–225) 114 (079–164) 120 (093–155) 201 (120–336)
Sex (male) 149 (118–189) 098 (071–135) 083 (066–104) 121 (080–183)
Ethnicity (non-European) 102 (076–136) 104 (069–158) 135 (103–178) 174 (109–279)
Breastfeeding (ever) 090 (058–139) 083 (045–153) 091 (059–140) 069 (034–139)
Child day care(yes) 106 (081–139) 122 (082–180) 121 (092–158) 149 (088–250)
Pet exposure (yes) 088 (068–114) 082 (057–119) 110 (085–142) 067 (041–111)
Wheezing pattern (early) 120 (088–162) 105 (071–155) 114 (085–152) 087 (047–158)
Wheezing pattern (late) 265 (167–420) 123 (054–280) 123 (068–225) 363 (171–771)
Wheezing pattern (persistent) 267 (194–369) 127 (074–217) 189 (136–265) 350 (203–604)
Values are pooled odds ratios with their 95% confidence intervals. All environmental exposure were entered simultaneously in the model.
Reference groups are ‘never eczema’ phenotype group (n = 4018), and multiparous, primary education, no parental history of eczema,
allergy or asthma, female sex, never breastfeeding, no day care attendance, no pet exposure or never wheezing groups. Bold values indicate
statistical significance at the a = 005 level.
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The observations in this study support the view that nullipar-
ity, parental history of eczema, allergy and asthma, late-onset
and persistent wheezing, FLG genotype and the genetic risk
score based on previously identified SNPs are risk factors for
childhood eczema.6,12,15,16 The functions of many of these
SNPs are not yet determined, but may be related to autoimmu-
nity and skin barrier.13 A previous study suggests that children
of Surinamese–Creole and Surinamese–Hindustani origin have
an increased risk of eczema.22 In addition, this study showed
that Asian and African children had an up to 36-fold increased
risk of late transient and persistent eczema compared with Euro-
pean children. Possible underlying mechanisms include differ-
ences in skin barrier properties, parental psychological distress,
microbiome development and other genetic factors.11,22,32
In contrast to the literature, no associations were observed
between breastfeeding and eczema phenotypes. However,
most literature focused on the presence or absence of eczema
and not on distinct phenotypes, or a univariate analysis was
used.15 Even though favourable effects have been found
between pet exposure and eczema, we did not find any effect
between postnatal pet exposure and eczema phenotypes.8 This
is in line with previous studies on eczema phenotypes.15,16
Differences between our study and the previous literature
might be due to the timing of the measurements, different
distribution of risk factors or mild severity of included eczema
cases as is illustrated by the low prevalence of FLG mutations
in our multiethnic paediatric population.12
The number of eczema phenotypes is based on statistical fit
and depends on clinical relevance. The three eczema
phenotypes identified by latent class growth analysis might
present a more useful model for clinical practice, because it
makes a clearer distinction between transient and persistent
eczema. All patients with eczema should receive optimal care,
but it would be useful to identify children with a higher
chance of developing persistent eczema, as they may well ben-
efit from earlier, more aggressive, treatment.33 For future
studies, it would be clinically relevant to know whether indi-
viduals with specific eczema phenotypes are more prone to
develop other atopic diseases, such as asthma and/or food
allergies. From an aetiological point of view, it is important to
improve the identification of specific early-life environmental
exposures and genetic risk factors in the development and per-
sistency of eczema. A sufficient number of cases of eczema
and detailed information on endogenic factors are needed to
compare immunological response, skin barrier defects and
genetic predisposition in children with different eczema
phenotypes.
The strengths of this study include the prospective popula-
tion-based design, multiethnic population with detailed infor-
mation on eczema, early environmental exposures and genetic
factors. Our eczema phenotypes model seems valid for a multi-
ethnic population in an ever-globalizing world. Latent class
growth analysis is an objective method to identify classes
within a population. More precise and unbiased effect esti-
mates are obtained by using multivariate multinomial models
based on imputed data. However, some methodological limi-
tations to this study need to be considered. We assumed that
data was missing at random. It is always a possibility that
Table 3 The associations of genetic risk factors with eczema phenotypes and three separate sensitivity analysis investigating the associations
between early environmental exposures, genetic risk factors and/or ethnicity and eczema phenotypes
Early transient eczema Mid-transient eczema Late transient eczema Persistent eczema
Genetic risk factor model, n = 2981 n = 258 n = 177 n = 235 n = 76
FLG genotype (≥ 1 mutations) 221 (140–349) 152 (073–315) 209 (130–334) 168 (069–409)
Genetic risk score (per additional allele) 108 (103–113) 106 (099–113) 102 (098–106) 109 (101–118)
Environmental exposure model and
genetic risk factors (i), n = 2981
n = 258 n = 177 n = 235 n = 76
FLG genotype (≥ 1 mutations) 221 (139–350) 156 (075–324) 202 (126–324) 180 (073–447)
Genetic risk score (per additional allele) 107 (102–112) 105 (099–112) 101 (097–106) 109 (100–118)
Environmental exposure model in
ethnic subgroups (ii), n = 5297
n = 439 n = 306 n = 412 n = 122
Ethnicity (Mediterranean) 078 (048–126) 044 (018–105) 112 (072–174) 110 (050–240)
Ethnicity (Asian) 127 (078–206) 166 (091–301) 183 (120–280) 226 (111–460)
Ethnicity (African) 135 (089–205) 111 (060–206) 149 (100–223) 201 (106–379)
Environmental exposure and genetic
model in ethnic subgroups (iii), n = 2981
n = 258 n = 177 n = 235 n = 76
Ethnicity (Mediterranean) 099 (053–186) 057 (019–170) 141 (079–249) 100 (035–283)
Ethnicity (Asian) 143 (075–273) 195 (088–431) 204 (114–365) 308 (134–710)
Ethnicity (African) 135 (077–237) 168 (082–343) 143 (081–250) 180 (077–417)
Values are pooled odds ratios with their 95% confidence intervals. The genetic risk factor model was adjusted for ethnicity only. The envi-
ronmental exposure model was mutually adjusted for all environmental exposures as presented in Table 1, and additionally adjusted for (i)
genetic risk factors, (ii) ethnic subgroups and (iii) for genetic risk factors and ethnic subgroups. Reference groups are the ‘never eczema’
phenotype group, and European ethnicity, or no FLG mutation group. Effect estimates for the association of early environmental exposures
with eczema phenotypes additionally adjusted for the genetic risk factors and ethnicities subgroups are shown in Tables S4–S6 (see Support-
ing Information). Bold values indicate statistical significance at the a = 005 level.
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missing data is not missing at random, which might lead to
biased estimates.34 Including children with at least 50% of the
data observed ensures a more reliable model. Selection bias
might be present if the associations of the selected environ-
mental and genetic factors with eczema phenotypes were dif-
ferent for the children included and those who were not
included in the analyses. Furthermore, we cannot rule out
under-reporting or misreporting of eczema. However, there is
evidence that parent-reported physician-diagnosed eczema is
sufficient for epidemiological research and eczema prevalence
in our study is similar to that of the Dutch population.33,35
No information was available to determine the severity of
eczema or subtypes of eczema, which could have influenced
the observed effect estimates and associations, and there is a
possibility that residual confounding may have occurred. Also,
a longer follow-up period could influence the number and
pattern of eczema phenotypes. The uncertainty of class assign-
ment of children is only partially accounted for by using
weights in the multinomial analyses. Moreover, the results were
not adjusted for multiple testing. We extracted the SNPs from
the most recent GWA study that included non-European popula-
tions; however, most of the genetic risk factors, including FLG
mutations, have been discovered in European populations.13
Although early transient and persistent eczema appear to share
several determinants, most of the selected environmental and
genetic factors did not strongly differentiate between the various
eczema phenotypes. This may partly be explained by minimiz-
ing the number of categories per factor in order to maximize
the number of factors required to maintain appropriate statisti-
cal models. Future large-scale studies examining early-life envi-
ronmental exposures in more detail could provide better
differentiation between eczema phenotypes.
In conclusion, five eczema phenotypes were identified in a
multiethnic paediatric cohort followed from birth until the
age of 10 years. Previously known eczema risk factors differ-
entiated between the different phenotypes to a limited degree.
Male sex and Asian and African ethnicity were differently
associated with eczema phenotypes and therefore could be
useful for prediction purposes. Further studies are needed to
compare the trajectories of different eczema phenotypes and
identify other potential predictive factors, ideally in a ‘hypoth-
esis-free approach’ as known risk factors are relatively poor
discriminators, in order to improve eczema management and
prevention strategies.
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Fig S1. (a) Three eczema phenotypes after longitudinal
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dinal latent class analysis.
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